Metal Nanoparticles: Advanced and Promising Technology in Diabetic Wound Therapy

Qinzhou Zheng,Cuimin Chen,Yong Liu,Jie Gao,Luxin Li,Chuan Yin,Xiaohuan Yuan
DOI: https://doi.org/10.2147/ijn.s434693
IF: 7.033
2024-01-27
International Journal of Nanomedicine
Abstract:Qinzhou Zheng, 1, &ast Cuimin Chen, 2, &ast Yong Liu, 3 Jie Gao, 2, &ast Luxin Li, 1 Chuan Yin, 4 Xiaohuan Yuan 1 1 College of Life Science, Mudanjiang Medical University, Mudanjiang, People's Republic of China; 2 Changhai Clinical Research Unit, Shanghai Changhai Hospital, Naval Medical University, Shanghai, 200433, People's Republic of China; 3 Center for Comparative Medicine, Mudanjiang Medical University, Mudanjiang, People's Republic of China; 4 Department of Gastroenterology, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, 200003, People's Republic of China &astThese authors contributed equally to this work Correspondence: Chuan Yin, Department of Gastroenterology, Shanghai Changzheng Hospital, Naval Medical, University, Shanghai, 200003, People's Republic of China, Email Xiaohuan Yuan, College of Life Science, Mudanjiang Medical University, Mudanjiang, 157001, Heilongjiang, People's Republic of China, Tel/Fax +86-453-6984647, Email Diabetic wounds pose a significant challenge to public health, primarily due to insufficient blood vessel supply, bacterial infection, excessive oxidative stress, and impaired antioxidant defenses. The aforementioned condition not only places a significant physical burden on patients' prognosis, but also amplifies the economic strain on the medical system in treating diabetic wounds. Currently, the effectiveness of available treatments for diabetic wounds is limited. However, there is hope in the potential of metal nanoparticles (MNPs) to address these issues. MNPs exhibit excellent anti-inflammatory, antioxidant, antibacterial and pro-angiogenic properties, making them a promising solution for diabetic wounds. In addition, MNPs stimulate the expression of proteins that promote wound healing and serve as drug delivery systems for small-molecule drugs. By combining MNPs with other biomaterials such as hydrogels and chitosan, novel dressings can be developed and revolutionize the treatment of diabetic wounds. The present article provides a comprehensive overview of the research progress on the utilization of MNPs for treating diabetic wounds. Building upon this foundation, we summarize the underlying mechanisms involved in diabetic wound healing and discuss the potential application of MNPs as biomaterials for drug delivery. Furthermore, we provide an extensive analysis and discussion on the clinical implementation of dressings, while also highlighting future prospects for utilizing MNPs in diabetic wound management. In conclusion, MNPs represent a promising strategy for the treatment of diabetic wound healing. Future directions include combining other biological nanomaterials to synthesize new biological dressings or utilizing the other physicochemical properties of MNPs to promote wound healing. Synthetic biomaterials that contain MNPs not only play a role in all stages of diabetic wound healing, but also provide a stable physiological environment for the wound-healing process. Keywords: metal nanoparticles, wound healing, diabetic wound, drug delivery, antibacterial activity Diabetes mellitus (DM) is a prevalent endocrine disorder characterized primarily by elevated blood glucose levels resulting from either insulin resistance or diminished insulin secretion. 1 The occurrence of DM in the adult population is expected to grow by 69% in developing nations and 20% in affluent countries by 2030 in comparison to 2010. 2 The number of Americans with diabetes is expected to triple. 3 Prolonged hyperglycemia can cause a variety of organ lesions in diabetic patients, including diabetic nephropathy, skin ulcers, retinopathy, and neuropathy. 4 In diabetes, the failure of wound healing is attributed to macrovascular and microvascular lesions, leading to complications that are a major cause of increased diabetes-related morbidity and mortality. 5 Moreover, the high glucose environment of the wound makes the wound susceptible to infection, which also leads to slow and worse wound recovery. The current treatment methods mainly include blood glucose control, surgical debridement, skin transplantation, wound dressing change and other conventional treatment methods. However, conventional treatments only clean the wound and do not effectively promote the healing of diabetic wounds. Therefore, advancing treatment of diabetic wounds requires the addition of innovative biomaterials and bioactive substances. These novel interventions are designed to accelerate wound healing and minimize unattractive scar formation by means of anti-inflammatory, antioxidant, and antimicrobial agents. 6 Among the various emerging technologies, MNPs have shown great -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology
What problem does this paper attempt to address?